- LogicBio press release ( NASDAQ: LOGC ): Q3 GAAP EPS of -$0.18 beats by $0.02 .
- Revenue of $2.72M (+28.3% Y/Y) beats by $0.72M .
- Shares -0.48% PM.
For further details see:
LogicBio GAAP EPS of -$0.18 beats by $0.02, revenue of $2.72M beats by $0.72MFor further details see:
LogicBio GAAP EPS of -$0.18 beats by $0.02, revenue of $2.72M beats by $0.72MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
LogicBio Therapeutics Inc. Company Name:
LOGC Stock Symbol:
Market:
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates PR Newswire - Pre-clinical results published in PLOS ONE demonstrating a single intravenous administration of mLB-001 in neonatal or adult MMA mice correlated with preventi...
NEW YORK, NY / ACCESSWIRE / October 20, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: KnowBe4, Inc. (NASDAQ:KNBE)'s s...
NEW YORK, NY / ACCESSWIRE / October 16, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: LogicBio Therapeutics, Inc. (NASD...